Matches in SemOpenAlex for { <https://semopenalex.org/work/W4379523298> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W4379523298 endingPage "469" @default.
- W4379523298 startingPage "468.1" @default.
- W4379523298 abstract "Background Single cell technologies (scRNAseq) are increasingly applied in rheumatology to identify key cellular phenotypes that drive disease pathogenesis, enabling to deconvolute cellular heterogeneity within tissues. Objectives To investigate ST heterogeneity in terms of myeloid cells enrichment and distribution across different disease phases on ST samples obtained from US-guided biopsies in a bio-samples dataset of patients with Psoriatic Arthritis (PsA). Methods 17 patients fulfilling the CASPAR criteria [1] for PsA underwent US-guided ST biopsy and were included. At baseline, patients were categorized based on their disease phase: n=4 naïve to DMARDs; n=3 resistant to c-DMARDs; n=5 resistant to b-DMARDs; n=2 Difficult to treat and n=3 in sustained clinical and US remission or in low disease activity (LDA) state. All ST specimens were processed for phenotyping and sorting. Alive cells were sorted and loaded onto a Chromium Controller (10x Genomics) for single-cell partitioning, followed by library preparation according to the Chromium Next GEM Single Cell 3′ Reagent Kits v3.1 (Dual Index) protocol. Single-cell libraries were sequenced on the Illumina HiSeq 4000 system to a minimum depth of 20,000 reads per cell. Results After standard data processing and quality control procedures, we obtained transcriptomic profiles for 16701 synovial tissue-derived cells. For analysis of ST myeloid compartment only, 10194 cells were computationally isolated with the subset function from other cell types based on expression of CD14,MARCO,LYZ,CD11b and CD64. We identified 10 different myeloid subclusters from the scRNA-seq profiles using SCTransform integration: 2 clusters of lining layer and 8 sublining layer macrophage named after main differentially expressed (DE) genes (adjusted P < 0.05 by Bonferroni correction and multiple test correction, multiplied by number of tests) and according to the nomenclature established in Alivernini et al 20202. Each cell type group is present across all disease conditions but differences in relative proportions were detected.Specifically, ST of patients with active PsA resistant to pharmacological treatment was significantly enriched in sublining MerTKnegSPP1pos macrophages. In addition, we observed pro-inflammatory changes in lining layer TREM2pos STMs as compared to patients who achieved Remission/LDA status(p<0.001 for both). Conclusion MerTKnegSPP1pos STM macrophage may contribute to synovial pathology of PsA resistant to pharmacological treatment. References [1]Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H; CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006 Aug;54(8):2665-73. doi: 10.1002/art.21972. PMID: 16871531. Acknowledgements: NIL. Disclosure of Interests None Declared." @default.
- W4379523298 created "2023-06-07" @default.
- W4379523298 creator A5007952296 @default.
- W4379523298 creator A5013878143 @default.
- W4379523298 creator A5028513437 @default.
- W4379523298 creator A5029502031 @default.
- W4379523298 creator A5029944861 @default.
- W4379523298 creator A5045989939 @default.
- W4379523298 creator A5049298945 @default.
- W4379523298 creator A5052191975 @default.
- W4379523298 creator A5055735434 @default.
- W4379523298 creator A5059017027 @default.
- W4379523298 creator A5062306011 @default.
- W4379523298 creator A5071500596 @default.
- W4379523298 creator A5071734527 @default.
- W4379523298 creator A5084542402 @default.
- W4379523298 creator A5085647114 @default.
- W4379523298 creator A5047819397 @default.
- W4379523298 date "2023-05-30" @default.
- W4379523298 modified "2023-10-01" @default.
- W4379523298 title "POS0425 SINGLE-CELL RNA SEQUENCING OF SYNOVIAL TISSUE-DERIVED MYELOID CELLS IN PSORIATIC ARTHRITIS PATIENTS ACROSS DISEASE PHASES" @default.
- W4379523298 doi "https://doi.org/10.1136/annrheumdis-2023-eular.3047" @default.
- W4379523298 hasPublicationYear "2023" @default.
- W4379523298 type Work @default.
- W4379523298 citedByCount "0" @default.
- W4379523298 crossrefType "journal-article" @default.
- W4379523298 hasAuthorship W4379523298A5007952296 @default.
- W4379523298 hasAuthorship W4379523298A5013878143 @default.
- W4379523298 hasAuthorship W4379523298A5028513437 @default.
- W4379523298 hasAuthorship W4379523298A5029502031 @default.
- W4379523298 hasAuthorship W4379523298A5029944861 @default.
- W4379523298 hasAuthorship W4379523298A5045989939 @default.
- W4379523298 hasAuthorship W4379523298A5047819397 @default.
- W4379523298 hasAuthorship W4379523298A5049298945 @default.
- W4379523298 hasAuthorship W4379523298A5052191975 @default.
- W4379523298 hasAuthorship W4379523298A5055735434 @default.
- W4379523298 hasAuthorship W4379523298A5059017027 @default.
- W4379523298 hasAuthorship W4379523298A5062306011 @default.
- W4379523298 hasAuthorship W4379523298A5071500596 @default.
- W4379523298 hasAuthorship W4379523298A5071734527 @default.
- W4379523298 hasAuthorship W4379523298A5084542402 @default.
- W4379523298 hasAuthorship W4379523298A5085647114 @default.
- W4379523298 hasBestOaLocation W43795232981 @default.
- W4379523298 hasConcept C104317684 @default.
- W4379523298 hasConcept C126322002 @default.
- W4379523298 hasConcept C142724271 @default.
- W4379523298 hasConcept C1491633281 @default.
- W4379523298 hasConcept C150194340 @default.
- W4379523298 hasConcept C162317418 @default.
- W4379523298 hasConcept C203014093 @default.
- W4379523298 hasConcept C2775934546 @default.
- W4379523298 hasConcept C2776260265 @default.
- W4379523298 hasConcept C2777077863 @default.
- W4379523298 hasConcept C2779282312 @default.
- W4379523298 hasConcept C54355233 @default.
- W4379523298 hasConcept C71924100 @default.
- W4379523298 hasConcept C86803240 @default.
- W4379523298 hasConceptScore W4379523298C104317684 @default.
- W4379523298 hasConceptScore W4379523298C126322002 @default.
- W4379523298 hasConceptScore W4379523298C142724271 @default.
- W4379523298 hasConceptScore W4379523298C1491633281 @default.
- W4379523298 hasConceptScore W4379523298C150194340 @default.
- W4379523298 hasConceptScore W4379523298C162317418 @default.
- W4379523298 hasConceptScore W4379523298C203014093 @default.
- W4379523298 hasConceptScore W4379523298C2775934546 @default.
- W4379523298 hasConceptScore W4379523298C2776260265 @default.
- W4379523298 hasConceptScore W4379523298C2777077863 @default.
- W4379523298 hasConceptScore W4379523298C2779282312 @default.
- W4379523298 hasConceptScore W4379523298C54355233 @default.
- W4379523298 hasConceptScore W4379523298C71924100 @default.
- W4379523298 hasConceptScore W4379523298C86803240 @default.
- W4379523298 hasIssue "Suppl 1" @default.
- W4379523298 hasLocation W43795232981 @default.
- W4379523298 hasOpenAccess W4379523298 @default.
- W4379523298 hasPrimaryLocation W43795232981 @default.
- W4379523298 hasRelatedWork W1915888164 @default.
- W4379523298 hasRelatedWork W2004879554 @default.
- W4379523298 hasRelatedWork W2040474392 @default.
- W4379523298 hasRelatedWork W2146454545 @default.
- W4379523298 hasRelatedWork W2182099883 @default.
- W4379523298 hasRelatedWork W2357437675 @default.
- W4379523298 hasRelatedWork W2369623981 @default.
- W4379523298 hasRelatedWork W2903217807 @default.
- W4379523298 hasRelatedWork W2989481796 @default.
- W4379523298 hasRelatedWork W3007410422 @default.
- W4379523298 hasVolume "82" @default.
- W4379523298 isParatext "false" @default.
- W4379523298 isRetracted "false" @default.
- W4379523298 workType "article" @default.